Donald Trump’s imposed import tariffs across the globe have dominated the headlines and caused significant turmoil in the markets. However, what hasn’t received much reporting is the tariff exemption given to the UK life sciences sector.

As the UK continues to reposition itself post-Brexit, this latest development could in fact signal opportunity, not just for drug manufacturers and researchers, but for architects, developers and contractors helping to shape the spaces where life sciences innovation happens.

…